Skip to main content
Download PDF

Sex differences in lower urinary tract biology and physiology

Biology of Sex Differences volume 9, Article number: 45 (2018) Cite this article

Abstract

Females and males differ significantly in gross anatomy and physiology of the lower urinary tract, and these differences are commonly discussed in the medical and scientific literature. However, less attention is dedicated to investigating the varied development, function, and biology between females and males on a cellular level. Recognizing that cell biology is not uniform, especially in the lower urinary tract of females and males, is crucial for providing context and relevance for diverse fields of biomedical investigation. This review serves to characterize the current understanding of biological sex differences between female and male lower urinary tracts, while identifying areas for future research. First, the differences in overall cell populations are discussed in the detrusor smooth muscle, urothelium, and trigone. Second, the urethra is discussed, including anatomic discussions of the female and male urethra followed by discussions of cellular differences in the urothelial and muscular layers. The pelvic floor is then reviewed, followed by an examination of the sex differences in hormonal regulation, the urinary tract microbiome, and the reticuloendothelial system. Understanding the complex and dynamic development, anatomy, and physiology of the lower urinary tract should be contextualized by the sex differences described in this review.

Background

Sex refers to the biological classification of living things, generally as female or male, whereas gender is an individual’s self-representation shaped by social and cultural associations with biological sex [1]. Both sex and gender can impact diagnosis and treatment in all areas of health and disease and, as a result, all areas of research should account for sex and gender in study design, analysis, interpretation, and data reporting. The ability to reproduce experimental data and the generalizability of results depend on such efforts [2].

Sex differentiation plays a key role in lower urinary tract (LUT) development and function. The foci of current research on LUT sex differences are anatomical and physiological differences, while little attention has been paid to sex differences at the cellular level of the LUT. Further investigation of sex differences in LUT cell types is needed to better develop our understanding of normal and abnormal LUT function [3]. Elucidation of these differences in the LUT is essential to providing optimal treatment for urinary dysfunction in both women and men.

This review will cover the current research on sex differences in the LUT, highlighting areas in need of more research. With new NIH policies in place regarding sex as a biological variable [4], the review may serve as guide on the current status of sex differences in the LUT at the cellular level and indicate where future research efforts are needed.

Cell populations in or associated with the LUT

Detrusor smooth muscle

The bladder provides a continent, neurologically controlled, compliant reservoir for urinary storage and a method to consciously void when appropriate. Voiding is controlled by the detrusor, which is the smooth muscle (SM) in the wall of the bladder from the insertion of the ureters to the dome (top) of the bladder. Three layers of SM comprise the detrusor. Longitudinal cells populate the inner and outer layers, whereas those cells found in the middle are arranged in a circular manner [5]. In humans, SM cells of varying sizes can form bundles that are connected by collagen fibers [6]. The bundles have the potential to function as a unit, or fascicle [5]. The interactions occurring amongst the SM cells dictate the behavior of the bladder wall.

The detrusor is thicker in men than women, as greater voiding pressure is needed to empty the bladder through the longer urethra of males [7]. The ratio between SM and connective tissue does not differ between women and men of any age [8]. Furthermore, it has been reported that contractility of human detrusor is sex-independent [9].

The human fetal bladder can be detected after the tenth week post-conception. Although it was classically thought that the bladder trigone is mesodermal in origin and the remainder of the bladder is derived from the endoderm, some studies have shown that trigone is also endodermal [10]. Favorito et al. evaluated the morphological differences in SM development between females and males [11], observing no differences in the volumetric densities of fetal nerve, SM cells, or collagen of either sex (13–20 weeks post-conception) [11]. No studies to date have reported morphological or physiological differences between female and male SM cells.

Urothelium

The urothelium is a specialized epithelium that lines the lumen and is five to seven cells thick, divided into three layers: an apical layer (comprised of umbrella cells only, one cell layer thick that is in contact with urine), an intermediate layer (comprised of intermediate cells, two to three cells thick), and a basal layer (comprised of basal cells two to three cells thick). The mucosa of the bladder is comprised of the urothelium and the underlying lamina propria [9]. Umbrella cells serve as a barrier between the urine and the underlying tissue. When the bladder is filled, the umbrella cells are stretched and flattened; whereas when the bladder is empty, the cells are cuboidal [12]. Seventy to 90% of the luminal facing membrane of the umbrella cells are covered by plaques giving the cells a “scalloped” appearance [9, 13]. Plaques are made from uroplakins (UPs) that form hexagonal-shaped macromolecular structures providing additional barrier function besides tight junction proteins between the umbrella cells [13].

To date, four UPs have been found: UPIa (27 kD), UPIb (28 kD), UPII (15 kD), and UPIII (47 kD) [14,15,16]. Hu et al. found defective glycosylation of UPs, smaller urothelial plaques, increased water permeability, vesicoureteral leakage, and enlarged ureteral orifices when UPIIa was deleted in both female and male mice [17, 18]. Aboushwareb et al. found sex-specific effects for UPIIa and UPIII knockout (KO) mice. For example, male UPII KO mice experienced bladder decompensation, including elevated pressure changes and increased residual volume; in contrast, female UPII KO mice emptied their bladders normally [19]. The same group studied the excitability of detrusor myocytes in UP KO mice and discovered that female mice demonstrated decreased excitability, but male mice experienced no change [19]. These data support the fact that uroplakin deficiency results in urothelial defects that can lead to sex-specific bladder dysfunction.

The urothelium serves an additional function besides barrier function. Because of numerous ion channels and receptor proteins such as epidermal growth factor receptors (EGFR), adenosine, adrenergic, bradykinin, neurokinin, muscarinic, and purinergic receptors [20], the urothelial cells can serve to either transduce signals to surrounding cells (other urothelial cells or lamina propria cells) or respond to signals from surrounding cells. Thus, the urothelial cells can have a dual role of “sensor-transducer” function [21].

Animal studies in both sexes have been conducted to determine the sensitivity of the urothelium to changes in pH. A family of acid-sensing ion channels (ASIC), H+-gated ion channels, are thought to help maintain pH within the urothelium of a mouse model [22]. ASIC1 is expressed in higher quantities in male mice, whereas ASIC2 is more abundant in females. The functional result of this difference in expression is unknown, although disruption of ASIC1 expression in the gut leads to a decrease in mechanical sensitivity [23]. The urothelium releases many small molecules and neurotransmitters in response to both mechanical and chemical stimuli [20]. Thus, ASIC may play a role in controlling bladder sensitivity to pH changes in the bladder.

Because the bladder urothelium plays an important role in the host innate immune response to UTI, and the fact that women are more prone to getting UTIs, the role of estrogen’s effect on the urothelial defense mechanisms has been examined. These studies have been performed in female mice or urothelial tissues from female human subjects. Estrogen was found to mediate urothelial defense mechanisms against uropathogenic Escherichia coli (UPEC) in mice [24, 25], and estrogen’s effect was through the ERβ and not the ERα receptor [24]. The translational relevance of these findings is that ERβ, and not ERα, is the estrogen receptor found in the bladder urothelium from female human subjects [26], and therefore, urothelial ERβ may play a more important role than ERα in UTI pathogenesis in women. A recent publication detected the presence of calcium-activated, voltage-gated, large conductance potassium channel (BK channel) on the umbrella urothelial cells [27]. Furthermore, urothelial BK channels were opened (activated) by lipopolysaccharides (LPS) suggesting that BK may work the same way in the urothelial cell as in macrophages where BK was important in regulating cytokine release when macrophages were exposed to LPS [28]. The possible link between BK and ERβ in urothelial innate immune response is suggested by the finding that estradiol increased expression of BK channels via ERβ [29]. Loss of estrogen (by ovariectomies) in mice resulted in loss of protection against increased voiding frequency induced by intravesical LPS [30]. Estrogen’s effects on the urothelium that protected against LPS’ effects involved urothelial genes involved in inflammation and cellular metabolism [30]. These publications highlight estrogen’s effects on bladder urothelium in urothelial defense mechanisms against UTI.

Trigone

The mechanistic basis of urinary continence involves relaxation of the detrusor and simultaneous contraction of the bladder neck. The trigone, a triangular-shaped complex of muscles, is demarcated by the bladder neck distally and the two ureters proximally [7]. The trigone is the least mobile aspect of the bladder as it is fused with the underlying detrusor that comprises the rest of the bladder [31]. In males, the bladder neck is contiguous with the prostatic urethra [7]. In females, both the bladder neck and urethra contact connective tissue of the anterior wall of the vagina; this positioning allows the bladder neck to be mobile but it is subject to stress, which can influence urinary continence [32]. A prime example is neuromuscular injury to the urethral sphincter during childbirth.

In males, the internal urethral sphincter is composed of SM that is arranged into long inner longitudinal and outer circular layers [33]. However, in women, the longitudinal cells do not form an internal sphincter. Oswald et al. found that although the growth of the bladder neck increased proportional to the gestational age, males (20–40-week gestation) have a denser internal sphincter and a significantly narrower bladder neck in comparison to females [34]. Similarly, Gilpin et al. showed that, in human fetuses, the circular SM around the bladder neck and proximal urethra was prominent in males but scant in females [35].This finding emphasizes the need for a sex-dependent study of the bladder neck during embryogenesis. Aside from looking at SM differentiation, more work is also needed to determine the exact populations of cells developing in the bladder neck.

Urethra

Female urethra

The adult female urethra is 3–4 cm in length [36, 37] (Fig. 1). It extends from the bladder neck to the external urethral orifice and is embedded behind the symphysis pubis [37]. Together, the bladder neck and proximal urethra form a functional rather than an anatomic internal sphincter. A cross section of the urethral wall reveals four tissue layers (from innermost to outer): (1) an inner epithelial lining, (2) a thick spongy sub-mucosa containing vascular supply, (3) a thin fascial layer, and (4) two layers of SM, an inner longitudinal layer and an outer circular layer [37, 38]. Although the proximal urethra in women is lined by transitional epithelial cells, this quickly transitions to squamous epithelial cells that line the majority of the female urethra [39].

Fig. 1
figure1

Anatomy and histology of female urethra. Reprinted from [37], with permission from Elsevier

Full size image

The female urethra also can be divided into several unique sections based on paraurethral structures [6]. The first 20% of the urethra lines the bladder neck, whereas the following 20–60% of urethral length is surrounded by the striated urethral sphincter. The next segment of the urethra is surrounded by urogenital diaphragm, followed by the distal 20%, which is surrounded by the bulbocavernosus muscle [40].

The distal sphincter, or rhabdosphincter, makes up the external urethral sphincter (EUS). The EUS, which is comprised of striated muscle in longitudinal and transverse configurations, is circular and incompletely surrounds the urethra. In females, the striated muscle located nearest to the vagina is significantly thinner, giving the rhabdosphincter a distinct horseshoe shape. Fibers from the trigonal plate bridge this incomplete ring [41]. Striated muscle in the distal urethral sphincter is circularly arranged and comprises the two bands that cover the ventral side of the urethra.

Male urethra

The male urethra has a diameter of 8–9 mm, is approximately 18–20 cm long, and is divided into the anterior and posterior urethra [37] (Fig. 2). The anterior urethra extends from the perineal membrane to the urethral meatus and is divided into the penile urethra (surrounded by the corpus spongiosum) and the fossa navicularis (surrounded by the glans penis). The posterior urethra begins at the bladder neck, extending distally to the perineal membrane, and is subdivided into the prostatic urethra (bladder neck to prostatic apex) and the membranous urethra (from prostatic apex to perineal membrane).

Fig. 2
figure2

Anatomy and histology of male urethra. Reprinted from [37], with permission from Elsevier

Full size image

The prostatic urethra is anteriorly displaced within the prostate and thus leaves the gland slightly anterior to the apex [42]. The urethral crest is a subtle ridge on the posterior aspect of the prostatic urethra that culminates in the verumontanum, an elevation in the posterior urethra that provides a crucial cystoscopic landmark for the male EUS. The male urethra angles about 30–35° anteriorly distal to the verumontanum.

The membranous urethra is a 2–2.5-cm stretch of urethra that passes through the perineal membrane and marks the site of the external sphincter, unique to the male urethra. Urothelium in the membranous urethra is surrounded by a layer of fibroelastic connective tissue (lamina propria) that separates it from the muscular layer, comprised of a thin SM layer and circularly oriented striated muscle fibers. This network of urethral muscle and connective tissue in addition to the pelvic floor muscles (described below) makes up the male EUS.

The bulbar urethra begins distal to the perineal membrane, which lies just anterior to the inferior margin of the pubic symphysis. After about 2 cm, the penile urethra begins which continues until it dilates into the fossa navicularis which is surrounded by the glans penis, until it terminates at the urethral meatus, the narrowest part of the urethra [43].

Urethral smooth muscle

The SM layer of the urethra contains oblique and longitudinal muscle fibers surrounded by circular fibers in both women and men [43]. These muscles are supported by pelvic floor muscles, described elsewhere in this review. Throughout the course of the urethra, the SM cell layer provides a baseline resistance to urine flow, which is reinforced by the rich vascularity of the urethra.

Both α1- and α2-adrenoceptors contribute to urethral SM contractility, relaxing during voiding and contracting during filling. Binding receptor assays reveal that male rabbits have equivalent amounts of α1- and α2-adrenoceptors, whereas the females have a significantly denser population of α2-adrenoceptors [44] (Table 1). To expand upon this finding, Alexandre et al. observed the effects of different agonists and antagonists on urethral SM in both mice and marmosets. Phenylephrine, norepinephrine, KCl, and electrical-field stimulation induced larger contractions in the male mice and marmosets [45]. However, there was no sex difference observed in response to N-nitro-l-arginine, atropine, or a P2X1-purinoceptor antagonist. Urethral mRNA expressions of α1A-adrenoceptor (a subtype of α1-adrenoceptors) and tyrosine hydroxylase were significantly higher for males than females [45]. It is a possibility therefore that α1-adrenoceptors are not as important for contraction and functionality in female rabbits.

Table 1 Urethral smooth muscle sex differences summary
Full size table

Few studies have specifically examined the differences in the development of female and male urethral SM. Oswald et al. studied fetal development of the internal urethral sphincter in 37 human fetuses. They found that the internal sphincter muscle of male fetuses had a significantly larger volume compared to female fetuses, in part due to hypertrophy of the SM at this level, leading to smaller lumens. They postulated that this could be resultant from hypertrophy induced by transient urethral obstruction distal to the bladder neck and hormone influenced (testosterone) dependent growth [34]. Important in both male and female fetuses, Jin et al. found that SM differentiation in the bladder and urethra is crucial for the Wolffian duct orifice descent [46].

Urethral striated muscle

Striated muscle in the LUT is essential for providing support to the pelvic floor and coordinating the initiation of micturition, the emptying of urine from the bladder. The architecture of striated muscle in these two locations is similar: an arrangement of muscle fibers and connective tissue (Table 2). From a macro-, micro-, to nano-scale, striated muscle is organized by whole muscle, muscle bundles, and muscle fibrils and myofibrils interlaced by connective tissue: epimysium, perimysium, and endomysium, respectively [47, 48]. There are two classifications for striated muscle fibers: slow twitch (type I) and fast twitch (type II). Type I fibers have more acid-stable ATPase, abundant mitochondria, thicker Z-disks, high amounts of strong oxidative enzymes, and a twitch tension of ~ 100 ms. Type II fibers have a higher concentration of alkaline-stable ATPases, fewer mitochondria, and a twitch tension of ~ 30 ms [49, 50]. Fiber type composition of striated muscle influences susceptibility to damage and repair and varies with sex as described below.

Table 2 Urethral striated muscle sex differences summary
Full size table

A comprehensive study of the striated sphincter muscle has been investigated in rats. Female and male urethras differ macro- and microscopically. Unlike typical skeletal muscles, female sphincter myofibrils are three to five times smaller in diameter than striated muscle from the pelvic floor [51]. This thinness corresponds to a lack of peripheral localization of nuclei. Instead, the nuclei are centrally localized and are of similar size to the diameter of the fibril. Additionally, unlike other skeletal muscles, these cells lack anchorage points and are in direct contact with neighboring connective tissue [51, 52]. In male rats, two longitudinal strips of connective tissue segment the sphincter into two lateral bundles; the myofibrils do not form myotendinous junctions with neighboring connective tissue [53]. Striated muscle forms a thick layer, observable by the eye, in male rats whereas in females, it is thin and circular [51].

Similar to skeletal muscle, desmin and dystrophin are expressed by rat striated urethral muscle; thus, both proteins are used for cell characterization. Desmin runs orthogonal to the Z-lines, outlining the sarcomeres, whereas dystrophin is localized in female rat sarcolemma [51]. Dystrophin is expressed in striated muscle but not urethral SM and is thus a good marker for differentiating between the two types of muscle [54]. Additionally, expression of slow and fast myosin heavy chains can be used to investigate striated muscle type using specific monoclonal antibodies. With the exception of the bladder neck, striated muscles prominently occupy the mid-region of the urethra [52]. Initially, it was thought that female rats contained a mixture of fast and slow fibers [55]. However, recent studies using immunohistochemistry have revealed that fast twitch fibers are predominant [51, 52, 56]. In male rats, Chen et al. observed 100% type II fast twitch fibers in the upper regions of the urethra [57]. Bierinx et al. found two types of myofibrils in male rats. All myofibrils expressed type II fast MHC similar to the female rat; however, in selected fibers taken near the urethral lumen, they co-expressed slow MHC [53]. In the female urethra, a thick layer of SM separates the lumen from the striated muscle. In males, SM is only observed near ducts (i.e., seminal, prostatic) and in the urethral lumen. Thus, Bierinx et al. hypothesize that the presence of these co-expressing fibrils in the male urethral lumen may play a role in continence similar to the SM in females [58].

Streng et al. used transvesical cystometry and ultrasound transducers to determine bladder pressure and flow rate changes in striated muscle taken from the distal regions of male and female urethras [59]. No sex difference was observed in bladder pressure oscillations and in discontinuous flow rates. However, a difference was observed in voiding mechanism. In females, the flow rate and bladder pressure are closely related; if the pressure increases, the flow begins and if the pressure decreases, the flow ceases. Although the flow is constant, it is interrupted for short periods of time when the bladder pressure increases and the urethral sphincter partially or fully closes. Streng et al. hypothesizes that this relationship is due to slow twitch fibers in females transiently closing the urethra and leading to pressure increments and flow stoppage [59]. Overall, female rats experience shorter micturition times and their maximal flow rate is lower. In males, there is a spike in flow before maximal bladder pressure is reached, followed by a slow decline in flow rate.

In addition to the extensive work in rats regarding the urethral striated muscle, human studies have also revealed key differences between males and females. In 1981, Gosling et al. observed a single population of type I (slow twitch) fibers, 15–20 μm in diameter, in both female and male EUS using histochemistry and electron microscopic analysis of samples obtained through cystourethrectomy [50]. They also observed a mixture of slow and fast fibers in the periurethral levator ani. Further studies conducted by Brading et al., Benoit et al., and Ho et al. revealed that in females, the striated muscle extends the length of the urethra and is composed of predominantly type I slow twitch fibers [60,61,62]. In males, striated muscle extends from the membranous urethra over the prostate and has a mixture of both slow and fast twitch fibers [63, 64]. Ho et al. observed two types of slow twitch fibers: one of smaller diameter (15.7 μm) and the other of larger diameter (21.7 μm). Aside from size, the difference between these two types of slow twitch fibers is unknown.

Identification of nitrergic nerve fibers within human rhadosphincter suggests that nitric oxide may play a role in striated muscle control in the urethra [63, 65]. Nitric oxide synthase (NOS) produces nitric oxide which mediates urethral SM relaxation in various animals [66,67,68]. Eighty-six percent of fast twitch and 29% of slow twitch fibers exhibited NOS immunoreactivity in the sarcolemma of the male EUS [63]. Since females have predominantly slow twitch fibers, further studies are needed to determine if there is a mixed slow twitch fiber population as seen in males. Additionally, the percentage of NOS immunoreactivity should be determined for women.

Pelvic floor striated muscle

The pelvic floor, or pelvic diaphragm, is a bowl-shaped structure that is composed of complex interconnected ligaments and striated muscles. This musculature provides support/resistance to abdominal pressure, supports abdominopelvic viscera, and aids in fecal and urinary continence [69]. The muscular components of the pelvic floor include the levator ani muscles and the coccygeus muscle [69, 70]. The levator ani is composed of three types of intermediate muscle fibers: the puborectalis, pubococcygeus, and iliococcygeus. These muscles are attached to the pelvis: anteriorly, behind the pubic bodies of the hip; laterally, fascia of the obturator internus muscle; posteriorly, coccyx. Gaps within the musculature, the urogenital hiatus and the rectal hiatus, allow for urination and defecation.

The puborectalis is U-shaped; originating at the pubic bone, it slings around and bends at the anorectal junction forming the anorectal angle (90°). Relaxing and contracting of the puborectalis maintains fecal continence [71]. The pubococcygeus fibers constitute the main muscle body in the levator ani. They initiate symmetrically at the pubis, run along the obturator internus, and attach together at the coccyx. Some fibers also loop around to surround the prostate in men (levator prostate) and the vagina in women (pubovaginalis). Within the pubococcygeal muscle is the anococcygeal ligament, which is a midline graft that extends from the anal cavity to the coccyx. Finally, the iliococcygeus muscle attaches at the coccyx and the posterior of the obturator internus, or the tendinous arch [42]. All three muscles of the levator ani attach laterally to the obturanus internal fascia where there is a thickening of fibers.

The levator ani muscles contain a heterogeneous population of type I and type II fibers, but histological analyses have shown that the type I, or slow twitch, fibers predominate [50] (Table 3). This correlates clinically with the static nature of the pelvic floor and its role in supporting the abdominal viscera. The smaller population of type II, fast twitch, fibers are likely recruited for assistance during periods of increased abdominal pressure (i.e., coughing, sneezing) [50]. The number and diameter of these fibers decrease with age [72]. There are no reported differences between females and males in the proportions of these fibers. A group of German investigators analyzed the pelvic floor muscles of young, healthy, female and male cadavers. Due to small sample size, no quantitative analyses were performed, but they reported no histomorphological differences between female and male specimens [73].

Table 3 Pelvic floor striated muscle sex difference summary
Full size table

In 1991, Tobin et al. showed that the levator ani muscle of the developing rat fetus exhibits sexual dimorphism [74]. Levator ani (LA) muscles were removed from 22-day-old female and male embryos and subjected to morphological analysis. The investigators found that female LA muscles contained significantly fewer motor units (MU) (153 versus 350) and each unit had comparatively smaller cross-sectional areas (89.2 μm2 versus 120.8 μm2). As the rats developed postnatally, the cross-sectional area of the MU decreased for both sexes and were equivalent by postnatal day 3 (approximately 33 μm2). Conversely, the number of motor units in males increased rapidly to 2726 by postnatal day 6, while in females, the number of MUs only increased modestly to 355. The authors posit that exposure to testosterone is responsible for this differential LA muscle development [74]. Satellite cells, a population of myogenic stem cells residing at the periphery of muscle fibers, seem to be influenced by androgens and may play a role in this sexual dimorphism. Niel et al. found that the number of satellite cells in the neonatal rat LA muscle was increased in males compared to females [75]. With prenatal exposure to testosterone, the number of satellite cells in the female group increased as well as the size of the LA muscle. The authors conclude that the sex differences found in the developing rat LA are attributed to sexual dimorphism in satellite cells, which may be androgen-sensitive [75].

These animal studies are in concordance with another study that investigated sex differences in the levator ani muscle of human fetuses [76]. They show that at the same point in development, the male levator ani muscle constitutes a thick muscular layer, while in the female, the LA muscle is thin and its bundles are integrated with connective tissue [76]. Further studies are necessary to elucidate the developmental differences between female and male pelvic floor musculature in humans.

Reticuloendothelial system (e.g., immune cells)

Urinary tract infections (UTIs) affect nearly 160 million individuals each year [77], and nearly half of women experience recurrence of UTIs [78]. Such sex-related vulnerability has been commonly attributed to anatomical differences involving the female lower urinary tract. Observations in support of this view include the fact that the female external urethra is in close proximity to the entrance of the vagina, which houses large numbers of microbes [79]. The current view is that bacteria migrate from the gut to the vagina and then to urethra, evidenced by the prevalence of native bowel flora that become uropathogens [57].

The mucosal layer of the urothelium is consistently exposed to countless microbes. Micturition is a passive mechanism for removing threats of infection. However, using single-molecule atomic force microscopy, Miller et al. found that uropathogenic E. coli (UPEC) utilize the flow of urine to extend adhesive surface appendages called pili to attach and secure themselves to the host epithelium [80]. The mucin layer provides a secondary defense, inhibiting bacterial attachment to the mucosal wall [81, 82].

While the mucosal layer is an important anatomical line of defense, more recent evidence supports the existence of nonstructural contributors rendering women more vulnerable to UTI. For the most part, this vulnerability is thought to stem from the reticuloendothelial system (RES), which provides the host immunity against microbes [83]. The RES includes antigen-presenting cells also known as MHII+, macrophages, dendritic cells, CD11b+ and CD103+ cells, and monocytes [83]. In addition, neutrophils and monocytes can enter the bladder upon UPEC infection [84, 85]. Mora-Bau et al. found that a majority of infiltrating monocytes differentiate into macrophages, which may then impair adaptive immune responses to UTI [83].

Mora-Bau et al. studied the role of prominent immune cells—CD45+, macrophages, dendritic cells, and monocytes—in bacterial clearance in female mice bladders [83]. Depletion of monocytes had little effect on bacterial clearance. Macrophages have been hypothesized to adapt an immune response via cytokine secretion or antigen sequestration. When depleting mice of macrophages, no change was observed for effecter cell infiltration or cytokine secretion; however, there was an increase in the number of dendritic cells containing UPEC cells [83]. In addition, absence of B and/or T cells severely impaired the defense of female bladders against UPEC [83]. Although there was an increase in immune response, it did not alter reinfection nor remove the bacteria. Also, mast cell-derived IL-10 enhanced immune tolerance and decreased response to infection in the bladder, enhancing the risk of chronic infection [86].

A study of cells in the mucosal layer biopsied from women found increased numbers of CD4+ and CD8+ cells for those with interstitial cystitis, suggesting these cells play a crucial role in the innate pathogenesis of the female bladder [87]. Interestingly, these increased numbers were found in the urothelium and not the detrusor. A thin layer of glycosaminoglycans populate the urothelium, and no difference was observed for either sex or by region of the rabbit bladder [88]. More research is needed to determine if the differences in rate of UTI between women and men is related to differences in the innate ability of the RES to fight infection.

Microbiome

Clinicians often equate the presence of bacteria in urine with infection. This concept is based on the long-held dogma that urine is sterile. Recently, however, researchers have used next-generation sequencing and enhanced culture methods to detect communities of bacteria, fungi, and viruses (microbiota) in catheterized urine collected directly from the female bladder [89,90,91,92,93,94,95]. Thus, the “sterile urine” paradigm is no longer valid. Other studies have revealed associations between bladder bacteria and post-operative and post-instrumentation UTIs [96, 97], urgency urinary incontinence [98, 99], and response to overactive bladder treatment [100]. These findings suggest that the urinary tract possesses its own protective microbiota and that disruption (dysbiosis) of this community results in LUT symptoms (for recent reviews, see [101,102,103]).

The bacteria most commonly detected in the bladders of adult women are members of the genera Lactobacillus, Gardnerella, Streptococcus, and Staphylococcus [98,99,100]. Typical uropathogens (e.g., UPEC) are rarely detected, except in women experiencing UTI symptoms. Indeed, the conventional view that UTI is almost always caused by UPEC is suspect, as the standard urine culture protocol performed by clinical microbiology laboratories worldwide misses the vast majority of non-E. coli uropathogens most of the time [104]. These results argue against the conventional E. coli-centric view of UTI [105].

While almost all bladder microbiota research has been performed in peri-menopausal women, preliminary studies of pregnant women and men have been reported. Intriguingly, the bladder microbiota of women whose pregnancies went to full term resemble those of older peri-menopausal women [106]. Live bacteria have also been detected in urine obtained by a catheter from older men. The study sample size is too small to conclude much, except that the male urinary bladder is probably also not sterile [127]. Thus, the discovery of the bladder microbiota offers an exciting opportunity to advance our understanding of LUT health and disease.

The role of hormones in sex differences in the LUT

Receptors for estrogen, progesterone, and testosterone can be found in the LUT of both sexes across species and across developmental time periods [107,108,109,110,111,112]. This suggests an important role for reproductive hormones in LUT development and/or maintenance, although the expression and underlying regulatory mechanisms of sex hormone receptor expression can vary between sexes.

In female and male mice, SM cells and lamina propria fibroblasts of the urethral wall had a high density of estrogen receptor-α (ERα), estrogen receptor-β (ERβ), and progesterone receptor (PR)-positive cells [112]. ERβ+ and PR+ cells have also been observed in the urethral epithelium, while ERβ+ cells are found in the bladder epithelium and detrusor of both sexes. In females, only ERβ was detected in the bladder urothelium [26]; whereas in male bladder urothelium, no ER expression was detected [113]. The caveat here is that the female study was done in 2009 after the discovery of ERβ in 1996 [114], whereas the male study was done in 1995 prior to the discovery of ERβ; thus, no antibody for ERβ was available. In males only, ERβ and PR are present in striated muscle cells of the rhabdosphincter. In females, PR co-localized mostly with ERα. Knocking out ERα in the LUT of female mice resulted in reduced numbers of PR-positive cells in the urethra, suggesting that ERα mediates PR expression in the female urethra [112]. In contrast, disrupting expression of either ERα or ERβ in males did not change PR expression in the urethra.

Reproductive hormones have also been shown to play a role in LUT structure and integrity. Female rats that have undergone oophorectomy have a thinner bladder wall and widened spaces between detrusor fascicles compared to controls [115]. Injections with either estrogen or testosterone reversed these effects [115]. In males, following castration either before or after puberty, pelvic neurons are significantly smaller than those in noncastrated control male rats [109]. Testosterone replacement following surgery remediated these effects, signifying that testosterone is important for maturation and maintenance of autonomic pelvic neurons in males [109]. In contrast, estrogen replacement had no effect on male rat pelvic ganglia [116].

In female rabbits, injections of either progesterone or testosterone slightly reduce bladder capacity and compliance, while treatment with estrogen increases bladder capacity and compliance [108, 117]. In male rabbits, injections of either testosterone or estrogen significantly increases bladder capacity but progesterone treatment has no effect [118]. The cyclical nature of estrogen and progesterone is associated with worsening LUT symptoms prior to menstruation [119]. Furthermore, urethral length is increased midcycle of the menstrual cycle, at a time of high estrogen, compared to other phases [120]. Vaginal estrogen has been shown to reduce LUT symptoms associated with genitourinary syndrome of menopause, such as UTIs and overactive bladder [119].

ERα, ERβ, and the androgen receptor (AR) are also thought to play a role in bladder cancer development and progression [121,122,123,124]. Some studies show that the loss of AR or ERα expression is associated with higher grade/more pathologic tumors in the bladder [121, 123], while increased expression of Erβ is associated with these same tumor types [123]. However, other studies show conflicting results [125].

It is clear that reproductive hormones have a role in LUT function and that these hormones can mediate different effects in females compared to males. What remains unknown is the mechanisms underlying the role of these hormones in the LUT of both sexes. Indirect effects of reproductive hormones, such as the role of estrogen in regulating adrenergic receptors in the LUT or its involvement in urothelial cell proliferation through different ER subtypes, have been demonstrated [126]. However, the presence of reproductive hormone receptors in both sexes suggests direct effects may also be possible [108].

Conclusions

Sex differences in LUT cells influence form and function. For example, variations in development of the rhabdosphincter result in the observed sexual dimorphism in voiding patterns, while differential expression of immune cells in the bladder mucosa or the differential responses of the urothelium may amplify the rate of urinary tract infections in women. Along with anatomical and functional variations between women and men, developmental and morphologic disparities on the cellular level need to be taken into account when treating pathology. Research in this field is still immature, and further investigation is needed to answer questions such as the following: How do sex differences in urinary microbiome impact susceptibility to urinary tract infections? How does the complex interplay between sex hormones and the lower urinary tract mediate development, physiology, and susceptibility to malignancy? Do sex differences in native reticuloendothelial system cell populations mediate variations in susceptibility to urinary tract infections? Can improved understanding of the complex development of male and female LUT stimulate breakthroughs in the diagnosis and management of LUT dysfunction? This review should serve as a guideline to current knowledge regarding LUT sex differences, as well as a catalyst for investigators wishing to contribute to the field.

Abbreviations

AR:

Androgen receptor

ASIC:

Acid-sensing ion channels

EGFR:

Epidermal growth factor receptors

ERα:

Estrogen receptor-α

Erβ:

Estrogen receptor-β

KO:

Knockout

LA:

Levator ani

LPS:

Lipopolysaccharides

LUT:

Lower urinary tract

MU:

Motor units

NOS:

Oxide synthase

PR:

Progesterone receptor

RES:

Reticuloendothelial system

SM:

Smooth muscle

UPEC:

Uropathogenic E. coli

UTI:

Urinary tract infection

References

  1. 1.

    Institute of Medicine. Exploring the biological contributions to human health: does sex matter? Washington, DC: The National Academies Press; 2001.

    Google Scholar 

  2. 2.

    Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature. 2014;505:612–3.

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Losada L, Amundsen CL, Ashton-Miller J, Chai T, Close C, Damaser M, DiSanto M, Dmochowski R, Fraser MO, Kielb SJ, et al. Expert panel recommendations on lower urinary tract health of women across their life span. J Women's Health (Larchmt). 2016;25:1086–96.

    Article  Google Scholar 

  4. 4.

    Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509:282–3.

    PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004;84:935–86.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  6. 6.

    DeLancey J, Gosling J, Creed K, Dixon J, Delmas V, Landon D, Norton P. Gross anatomy and cell biology of the lower urinary tract. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Second international consultation on incontinence. Plymouth: Health Publication; 2002. p. 17–82.

    Google Scholar 

  7. 7.

    Mangera A, Osman NI, Chapple CR. Anatomy of the lower urinary tract. Surg Oxf Int Ed. 2013;31:319–25.

    Google Scholar 

  8. 8.

    Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology. 1993;42:36–40.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Fry CH, Bayliss M, Young JS, Hussain M. Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle. BJU Int. 2011;108:E91–6.

    PubMed  Article  Google Scholar 

  10. 10.

    Tanaka ST, Ishii K, Demarco RT, JCt P, Brock JW 3rd, Hayward SW. Endodermal origin of bladder trigone inferred from mesenchymal-epithelial interaction. J Urol. 2010;183:386–91.

    PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Favorito LA, Pazos HM, Costa SF, Costa WS, Sampaio FJ. Morphology of the fetal bladder during the second trimester: comparing genders. J Pediatr Urol. 2014;10:1014–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Khandelwal P, Abraham SN, Apodaca G. Cell biology and physiology of the uroepithelium. Am J Physiol Ren Physiol. 2009;297:F1477–501.

    CAS  Article  Google Scholar 

  13. 13.

    Walz T, Haner M, Wu XR, Henn C, Engel A, Sun TT, Aebi U. Towards the molecular architecture of the asymmetric unit membrane of the mammalian urinary bladder epithelium: a closed “twisted ribbon” structure. J Mol Biol. 1995;248:887–900.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    Lin JH, Wu XR, Kreibich G, Sun TT. Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane. J Biol Chem. 1994;269:1775–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Wu XR, Sun TT. Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J Cell Sci. 1993;106(Pt 1):31–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Yu J, Lin JH, Wu XR, Sun TT. Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol. 1994;125:171–82.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Hu P, Deng FM, Liang FX, Hu CM, Auerbach AB, Shapiro E, Wu XR, Kachar B, Sun TT. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol. 2000;151:961–72.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Hu P, Meyers S, Liang FX, Deng FM, Kachar B, Zeidel ML, Sun TT. Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am J Physiol Ren Physiol. 2002;283:F1200–7.

    CAS  Article  Google Scholar 

  19. 19.

    Aboushwareb T, Zhou G, Deng FM, Turner C, Andersson KE, Tar M, Zhao W, Melman A, D'Agostino R Jr, Sun TT, Christ GJ. Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol Urodyn. 2009;28:1028–33.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Apodaca G, Balestreire E, Birder LA. The uroepithelial-associated sensory web. Kidney Int. 2007;72:1057–64.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Birder LA. Urothelial signaling. Handb Exp Pharmacol. 2011;202:207–31.

    CAS  Article  Google Scholar 

  22. 22.

    Kobayashi H, Yoshiyama M, Zakoji H, Takeda M, Araki I. Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. BJU Int. 2009;104:1746–51.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Page AJ, Brierley SM, Martin CM, Price MP, Symonds E, Butler R, Wemmie JA, Blackshaw LA. Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. Gut. 2005;54:1408–15.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Luthje P, Brauner H, Ramos NL, Ovregaard A, Glaser R, Hirschberg AL, Aspenstrom P, Brauner A. Estrogen supports urothelial defense mechanisms. Sci Transl Med. 2013;5:190ra180.

    Article  CAS  Google Scholar 

  25. 25.

    Wang C, Symington JW, Ma E, Cao B, Mysorekar IU. Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model. Infect Immun. 2013;81:733–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Tincello DG, Taylor AH, Spurling SM, Bell SC. Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract. J Urol. 2009;181:1474–82.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Lu M, Li JR, Alvarez-Lugo L, Li Y, Yu S, Li X, Shi B, Chai TC. Lipopolysaccharide stimulates BK channel activity in bladder umbrella cells. Am J Phys Cell Physiol. 2018;314:C643–53.

    CAS  Article  Google Scholar 

  28. 28.

    Papavlassopoulos M, Stamme C, Thon L, Adam D, Hillemann D, Seydel U, Schromm AB. MaxiK blockade selectively inhibits the lipopolysaccharide-induced I kappa B-alpha /NF-kappa B signaling pathway in macrophages. J Immunol. 2006;177:4086–93.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Li XT, Qiu XY. 17beta-estradiol upregulated expression of alpha and beta subunits of larger-conductance calcium-activated K(+) channels (BK) via estrogen receptor beta. J Mol Neurosci. 2015;56:799–807.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  30. 30.

    Acevedo-Alvarez M, Yeh J, Alvarez-Lugo L, Lu M, Sukumar N, Hill WG, Chai TC. Mouse urothelial genes associated with voiding behavior changes after ovariectomy and bladder lipopolysaccharide exposure. Neurourol Urodyn. 2018. https://doi.org/10.1002/nau.23592.

  31. 31.

    Aminu S. Trigonalgia: an overlooked cause of bladder pain. Afr J Urol. 2015;21:244–5.

    Article  Google Scholar 

  32. 32.

    Shah AP, Mevcha A, Wilby D, Alatsatianos A, Hardman JC, Jacques S, Wilton JC. Continence and micturition: an anatomical basis. Clin Anat. 2014;27:1275–83.

    PubMed  Article  Google Scholar 

  33. 33.

    Yucel S, Baskin LS. An anatomical description of the male and female urethral sphincter complex. J Urol. 2004;171:1890–7.

    PubMed  Article  Google Scholar 

  34. 34.

    Oswald J, Heidegger I, Steiner E, Brenner E, Rennau ML, Pichler R, Becker T, Loidl W, Horninger W, Fritsch H. Gender-related fetal development of the internal urethral sphincter. Urology. 2013;82:1410–5.

    PubMed  Article  Google Scholar 

  35. 35.

    Gilpin S, Gosling J. Smooth muscle in the wall of the developing human urinary bladder and urethra. J Anat. 1983;137:503.

    PubMed  PubMed Central  Google Scholar 

  36. 36.

    Corton MM. Normal anatomy of the pelvis and pelvic floor. In: Female pelvic medicine and reconstructive surgery, clinical practice and surgical atlas. Philadelphia: McGraw-Hill Education; 2013. p. 31–4.

  37. 37.

    Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2016.

  38. 38.

    Keegan KA, Nanigian DK, Stone AR. Female urethral stricture disease. Curr Urol Rep. 2008;9:419–23.

    PubMed  Article  PubMed Central  Google Scholar 

  39. 39.

    Cohen RJ, Garrett K, Golding JL, Thomas RB, McNeal JE. Epithelial differentiation of the lower urinary tract with recognition of the minor prostatic glands. Hum Pathol. 2002;33:905–9.

    PubMed  Article  Google Scholar 

  40. 40.

    DeLancey JO. Correlative study of paraurethral anatomy. Obstet Gynecol. 1986;68:91–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Haab F, Sebe P, Mondet F, Ciofu C. Functional anatomy of the bladder and urethra in females. In: Corcos J, Schick E, editors. The urinary sphincter. Boca Raton: Taylor & Francis Group; 2001. p. 15–24.

    Google Scholar 

  42. 42.

    Drake MJ, Fry CH, Eyden B. Structural characterization of myofibroblasts in the bladder. BJU Int. 2006;97:29–32.

    PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Baggish MS, Karram MM. Atlas of pelvic anatomy and gynecologic surgery. Philadelphia: Elsevier/Saunders; 2011.

    Google Scholar 

  44. 44.

    Morita T, Latifpour J, O'Hollaren B, Wheeler MA, Weiss RM. Sex differences in function and distribution of alpha 1- and alpha 2-adrenoceptors in rabbit urethra. Am J Phys. 1987;252:F1124–8.

    CAS  Google Scholar 

  45. 45.

    Alexandre EC, de Oliveira MG, Campos R, Kiguti LR, Calmasini FB, Silva FH, Grant AD, Yoshimura N, Antunes E. How important is the alpha1-adrenoceptor in primate and rodent proximal urethra? Sex differences in the contribution of alpha1-adrenoceptor to urethral contractility. Am J Physiol Ren Physiol. 2017;312:F1026–34.

    CAS  Article  Google Scholar 

  46. 46.

    Jin ZW, Abe H, Hinata N, Li XW, Murakami G, Rodriguez-Vazquez JF. Descent of mesonephric duct to the final position of the vas deferens in human embryo and fetus. Anat Cell Biol. 2016;49:231–40.

    PubMed  PubMed Central  Article  Google Scholar 

  47. 47.

    Downing K. Biochemistry and ultrastructure of pelvic floor tissues and organs. In: Biomechanics of the female pelvic floor: Elsevier; 2016. p. 181–208.

  48. 48.

    Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int. 2015;96:183–95.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Dixon J, Gosling J. Structure and innervation in the human. In: The physiology of the lower urinary tract. London: Springer; 1987. p. 3–22.

    Google Scholar 

  50. 50.

    Gosling JA, Dixon JS, Critchley HO, Thompson SA. A comparative study of the human external sphincter and periurethral levator ani muscles. Br J Urol. 1981;53:35–41.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Praud C, Sebe P, Mondet F, Sebille A. The striated urethral sphincter in female rats. Anat Embryol (Berl). 2003;207:169–75.

    Article  Google Scholar 

  52. 52.

    Lim SH, Wang TJ, Tseng GF, Lee YF, Huang YS, Chen JR, Cheng CL. The distribution of muscles fibers and their types in the female rat urethra: cytoarchitecture and three-dimensional reconstruction. Anat Rec (Hoboken). 2013;296:1640–9.

    Article  Google Scholar 

  53. 53.

    Bierinx AS, Sebille A. The urethral striated sphincter in adult male rat. Anat Embryol (Berl). 2006;211:435–41.

    Article  Google Scholar 

  54. 54.

    Byers TJ, Kunkel LM, Watkins SC. The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J Cell Biol. 1991;115:411–21.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  55. 55.

    Russell B, Baumann M, Heidkamp MC, Svanborg A. Morphometry of the aging female rat urethra. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7:30–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  56. 56.

    Buffini M, O'Halloran KD, O'Herlihy C, O'Connell R, Jones JF. Comparison of the contractile properties, oxidative capacities and fibre type profiles of the voluntary sphincters of continence in the rat. J Anat. 2010;217:187–95.

    PubMed  PubMed Central  Article  Google Scholar 

  57. 57.

    Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI. Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med. 2013;5:184ra160.

    Article  CAS  Google Scholar 

  58. 58.

    Smith PG, Bradshaw S. Innervation of the proximal urethra of ovariectomized and estrogen-treated female rats. Histol Histopathol. 2004;19:1109–16.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Streng T, Santti R, Talo A. Similarities and differences in female and male rat voiding. Neurourol Urodyn. 2002;21:136–41.

    PubMed  Article  PubMed Central  Google Scholar 

  60. 60.

    Benoit G, Quillard J, Jardin A. Anatomical study of the infra-montanal urethra in man. J Urol. 1988;139:866–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  61. 61.

    Brading AF. The physiology of the mammalian urinary outflow tract. Exp Physiol. 1999;84:215–21.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  62. 62.

    Ho K, McMurray G, Brading A, Noble J. The human female striated urethral sphincter consists of a heterogeneous population of muscle fibres. Br J Urol. 1997;79:13.

    Google Scholar 

  63. 63.

    Ho KM, McMurray G, Brading AF, Noble JG, Ny L, Andersson KE. Nitric oxide synthase in the heterogeneous population of intramural striated muscle fibres of the human membranous urethral sphincter. J Urol. 1998;159:1091–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  64. 64.

    Tokunaka S, Okamura K, Fujii H, Yachiku S. The proportions of fiber types in human external urethral sphincter: electrophoretic analysis of myosin. Urol Res. 1990;18:341–4.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  65. 65.

    Ho KM, Ny L, McMurray G, Andersson KE, Brading AF, Noble JG. Co-localization of carbon monoxide and nitric oxide synthesizing enzymes in the human urethral sphincter. J Urol. 1999;161:1968–72.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  66. 66.

    Bridgewater M, MacNeil HF, Brading AF. Regulation of tone in pig urethral smooth muscle. J Urol. 1993;150:223–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  67. 67.

    Persson K, Andersson KE. Non-adrenergic, non-cholinergic relaxation and levels of cyclic nucleotides in rabbit lower urinary tract. Eur J Pharmacol. 1994;268:159–67.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  68. 68.

    Persson K, Igawa Y, Mattiasson A, Andersson KE. Effects of inhibition of the L-arginine/nitric oxide pathway in the rat lower urinary tract in vivo and in vitro. Br J Pharmacol. 1992;107:178–84.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  69. 69.

    Livingston BP. Anatomy and neural control of the lower urinary tract and pelvic floor. Top Geriatr Rehabil. 2016;32:280–94.

    Article  Google Scholar 

  70. 70.

    Ashton-Miller JA, DeLancey JO. Functional anatomy of the female pelvic floor. Ann N Y Acad Sci. 2007;1101:266–96.

    PubMed  Article  PubMed Central  Google Scholar 

  71. 71.

    Hull T, Zutshi M. Pathophysiology, diagnosis, and treatment of defecatory dysfunction. In: Female urology. 3rd ed. Philadelphia: Elsevier; 2008. p. 761–72.

    Google Scholar 

  72. 72.

    Koelbl H, Strassegger H, Riss PA, Gruber H. Morphologic and functional aspects of pelvic floor muscles in patients with pelvic relaxation and genuine stress incontinence. Obstet Gynecol. 1989;74:789–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. 73.

    Jundt K, Kiening M, Fischer P, Bergauer F, Rauch E, Janni W, Peschers U, Dimpfl T. Is the histomorphological concept of the female pelvic floor and its changes due to age and vaginal delivery correct? Neurourol Urodyn. 2005;24:44–50.

    PubMed  Article  PubMed Central  Google Scholar 

  74. 74.

    Tobin C, Joubert Y. Testosterone-induced development of the rat levator ani muscle. Dev Biol. 1991;146:131–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  75. 75.

    Niel L, Willemsen KR, Volante SN, Monks DA. Sexual dimorphism and androgen regulation of satellite cell population in differentiating rat levator ani muscle. Dev Neurobiol. 2008;68:115–22.

    PubMed  Article  PubMed Central  Google Scholar 

  76. 76.

    Fritsch H, Frohlich B. Development of the levator ani muscle in human fetuses. Early Hum Dev. 1994;37:15–25.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  77. 77.

    Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653–60.

    Article  Google Scholar 

  78. 78.

    Johnson CC. Definitions, classification, and clinical presentation of urinary tract infections. Med Clin North Am. 1991;75:241–52.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  79. 79.

    Ingersoll MA, Albert ML. From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa. Mucosal Immunol. 2013;6:1041–53.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  80. 80.

    Miller E, Garcia T, Hultgren S, Oberhauser AF. The mechanical properties of E. coli type 1 pili measured by atomic force microscopy techniques. Biophys J. 2006;91:3848–56.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  81. 81.

    Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol. 1990;143:139–42.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  82. 82.

    Parsons CL, Greenspan C, Moore SW, Mulholland SG. Role of surface mucin in primary antibacterial defense of bladder. Urology. 1977;9:48–52.

    CAS  PubMed  Article  Google Scholar 

  83. 83.

    Mora-Bau G, Platt AM, van Rooijen N, Randolph GJ, Albert ML, Ingersoll MA. Macrophages subvert adaptive immunity to urinary tract infection. PLoS Pathog. 2015;11:e1005044.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  84. 84.

    Engel DR, Maurer J, Tittel AP, Weisheit C, Cavlar T, Schumak B, Limmer A, van Rooijen N, Trautwein C, Tacke F, Kurts C. CCR2 mediates homeostatic and inflammatory release of Gr1(high) monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection. J Immunol. 2008;181:5579–86.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  85. 85.

    Godaly G, Hang L, Frendeus B, Svanborg C. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol. 2000;165:5287–94.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  86. 86.

    Chan CY, St John AL, Abraham SN. Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity. 2013;38:349–59.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  87. 87.

    Christmas TJ. Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol. 1994;73:508–15.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  88. 88.

    Grist M, Chakraborty J. Identification of a mucin layer in the urinary bladder. Urology. 1994;44:26–33.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  89. 89.

    Ackerman AL, Underhill DM. The mycobiome of the human urinary tract: potential roles for fungi in urology. Ann Transl Med. 2017;5:31.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  90. 90.

    Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012;10:174.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  91. 91.

    Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, Brubaker L, Gai X, Wolfe AJ, Schreckenberger PC. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52:871–6.

    PubMed  PubMed Central  Article  Google Scholar 

  92. 92.

    Khasriya R, Sathiananthamoorthy S, Ismail S, Kelsey M, Wilson M, Rohn JL, Malone-Lee J. Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J Clin Microbiol. 2013;51:2054–62.

    PubMed  PubMed Central  Article  Google Scholar 

  93. 93.

    Miller-Ensminger T, Garretto A, Brenner J, Thomas-White K, Zambom A, Wolfe AJ, Putonti C. Bacteriophages of the urinary microbiome. J Bacteriol. 2018;200:e00738–17.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  94. 94.

    Santiago-Rodriguez TM, Fornaciari G, Luciani S, Dowd SE, Toranzos GA, Marota I, Cano RJ. Gut microbiome of an 11th century AD Pre-Columbian Andean mummy. PLoS One. 2015;10:e0138135.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  95. 95.

    Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50:1376–83.

    PubMed  PubMed Central  Article  Google Scholar 

  96. 96.

    Brubaker L, Nager CW, Richter HE, Visco A, Nygaard I, Barber MD, Schaffer J, Meikle S, Wallace D, Shibata N, Wolfe AJ. Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J. 2014;25:1179–84.

    PubMed  PubMed Central  Article  Google Scholar 

  97. 97.

    Pearce MM, Zilliox MJ, Rosenfeld AB, Thomas-White KJ, Richter HE, Nager CW, Visco AG, Nygaard IE, Barber MD, Schaffer J, et al. The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol. 2015;213:347.e1–11.

    Article  Google Scholar 

  98. 98.

    Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gregory WT, Rosenbaum JT, McWeeney SK, Nardos R. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol. 2016;6:78.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  99. 99.

    Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, Kliethermes S, Schreckenberger PC, Brubaker L, Gai X, Wolfe AJ. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio. 2014;5:e01283–14.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  100. 100.

    Thomas-White KJ, Hilt EE, Fok C, Pearce MM, Mueller ER, Kliethermes S, Jacobs K, Zilliox MJ, Brincat C, Price TK, et al. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J. 2016;27:723–33.

    PubMed  Article  PubMed Central  Google Scholar 

  101. 101.

    Brubaker L, Wolfe A. The urinary microbiota: a paradigm shift for bladder disorders? Curr Opin Obstet Gynecol. 2016;28:407–12.

    PubMed  PubMed Central  Article  Google Scholar 

  102. 102.

    Finucane TE. “Urinary tract infection” - requiem for a heavyweight. J Am Geriatr Soc. 2017;65:1650–5.

    PubMed  Article  PubMed Central  Google Scholar 

  103. 103.

    Mueller ER, Wolfe AJ, Brubaker L. Female urinary microbiota. Curr Opin Urol. 2017;27:282–6.

    PubMed  PubMed Central  Article  Google Scholar 

  104. 104.

    Price TK, Dune T, Hilt EE, Thomas-White KJ, Kliethermes S, Brincat C, Brubaker L, Wolfe AJ, Mueller ER, Schreckenberger PC. The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J Clin Microbiol. 2016;54:1216–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  105. 105.

    Price TK, Hilt EE, Dune TJ, Mueller ER, Wolfe AJ, Brubaker L. Urine trouble: should we think differently about UTI? Int Urogynecol J. 2018;29:205–10.

    PubMed  Article  Google Scholar 

  106. 106.

    Jacobs KM, Thomas-White KJ, Hilt EE, Wolfe AJ, Waters TP. Microorganisms identified in the maternal bladder: discovery of the maternal bladder microbiota. AJP Rep. 2017;7:e188–96.

    PubMed  PubMed Central  Article  Google Scholar 

  107. 107.

    Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int. 2000;86:32–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  108. 108.

    Celayir S. Is there a “bladder sex”? The relation of different sex hormones and sex hormone receptors in bladder in childhood. Med Hypotheses. 2002;59:186–90.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  109. 109.

    Keast JR, Saunders RJ. Testosterone has potent, selective effects on the morphology of pelvic autonomic neurons which control the bladder, lower bowel and internal reproductive organs of the male rat. Neuroscience. 1998;85:543–56.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  110. 110.

    Makela S, Strauss L, Kuiper G, Valve E, Salmi S, Santti R, Gustafsson JA. Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. Mol Cell Endocrinol. 2000;170:219–29.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  111. 111.

    McKenna KE, Nadelhaft I. The organization of the pudendal nerve in the male and female rat. J Comp Neurol. 1986;248:532–49.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  112. 112.

    Savolainen S, Santti R, Streng T, Gustafsson JA, Harkonen P, Makela S. Sex specific expression of progesterone receptor in mouse lower urinary tract. Mol Cell Endocrinol. 2005;230:17–21.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  113. 113.

    Bødker A, Balslev E, Juul BR, Stimpel H, Meyhoff H-H, Hedlund H, Hedlund P, Iversen H-G, Andersson K-E. Estrogen receptors in the human male bladder, prostatic urethra, and prostate: an immunohistochemical and biochemical study. Scand J Urol Nephrol. 1995;29:161–5.

    PubMed  Article  PubMed Central  Google Scholar 

  114. 114.

    Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925–30.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  115. 115.

    Yu Y, Shen Z, Zhou X, Chen S. Effects of steroid hormones on morphology and vascular endothelial growth factor expression in female bladder. Urology. 2009;73:1210–7.

    PubMed  Article  PubMed Central  Google Scholar 

  116. 116.

    Purves-Tyson TD, Arshi MS, Handelsman DJ, Cheng Y, Keast JR. Androgen and estrogen receptor-mediated mechanisms of testosterone action in male rat pelvic autonomic ganglia. Neuroscience. 2007;148:92–104.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  117. 117.

    Celayir S, Ilçe Z, Büyükünal S. Is there a bladder sex? The effects of sex hormones to female rabbit bladder I: an experimental study. BJU Int. 2000;85:40.

    Google Scholar 

  118. 118.

    Celayir S. Effects of different sex hormones on male rabbit urodynamics: an experimental study. Horm Res. 2003;60:215–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  119. 119.

    Robinson D, Toozs-Hobson P, Cardozo L. The effect of hormones on the lower urinary tract. Menopause Int. 2013;19:155–62.

    PubMed  Article  PubMed Central  Google Scholar 

  120. 120.

    Van Geelen JM, Doesburg WH, Thomas CM, Martin CB Jr. Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol. 1981;141:384–92.

    CAS  PubMed  Article  Google Scholar 

  121. 121.

    Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology. 2004;64:383–8.

    PubMed  Article  PubMed Central  Google Scholar 

  122. 122.

    Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst. 2007;99:558–68.

    CAS  PubMed  Article  Google Scholar 

  123. 123.

    Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int. 2012;109:1716–26.

    CAS  PubMed  Article  Google Scholar 

  124. 124.

    Teng J, Wang ZY, Jarrard DF, Bjorling DE. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Endocr Relat Cancer. 2008;15:351–64.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  125. 125.

    Mir C, Shariat SF, van der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S, Vajpeyi R, Kuk C, et al. Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int. 2011;108:24–30.

    PubMed  Article  PubMed Central  Google Scholar 

  126. 126.

    Levin RM, Shofer FS, Wein AJ. Estrogen-induced alterations in the autonomic responses of the rabbit urinary bladder. J Pharmacol Exp Ther. 1980;215:614–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  127. 127.

    Bajic P, Van Kuiken ME, Burge BK, Kirshenbaum EJ, Joyce CJ, Wolfe AJ, Branch JD, Bresler L, Farooq AV. The male bladder microbiome relates to lower urinary tract symptoms. Eur Urol Focus. 2018. https://doi.org/10.1016/j.euf.2018.08.001 [Epub ahead of print] PMID: 301434711.

Download references

Funding

This work was supported by programmatic grants from Astellas Pharma US, Inc., the Allergan Foundation, Cook Medical, and Kimberly-Clark Corp.

Author information

Author notes

  1. Benjamin Abelson and Daniel Sun contributed equally to this work.

Affiliations

  1. Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

    Benjamin Abelson, Daniel Sun & Margot S Damaser

  2. Department of Biophysics and Biophysical Chemistry, Johns Hopkins School of Medicine, Baltimore, MD, USA

    Lauren Que

  3. Society for Women’s Health Research, Washington, DC, USA

    Rebecca A Nebel

  4. UConn Center on Aging, University of Connecticut, 263 Farmington, Farmington, CT, USA

    Dylan Baker & George Kuchel

  5. Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA

    Patrick Popiel & Toby Chai

  6. Department of Obstetrics and Gynecology, Division of Urogynecology and Reconstructive Surgery, Duke University, Durham, NC, USA

    Cindy L Amundsen

  7. Department of Urology, Yale School of Medicine, New Haven, CT, USA

    Toby Chai

  8. Close Pediatric Urology, Henderson, NV, USA

    Clare Close

  9. Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ, USA

    Michael DiSanto

  10. Department of Surgery, Division of Urology, Duke University Medical Center, Durham, NC, USA

    Matthew O Fraser

  11. Department of Urology and Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Stephanie J Kielb

  12. Department of Urology, Loyola University Chicago, Maywood, IL, USA

    Elizabeth R Mueller

  13. Department of Obstetrics/Gynecology, Loyola University Chicago, Maywood, IL, USA

    Elizabeth R Mueller

  14. School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Mary H Palmer

  15. Department of Obstetrics and Gynecology, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Candace Parker-Autry

  16. Department of Urology, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Candace Parker-Autry

  17. Department of Microbiology and Immunology, Loyola University Chicago, Health Sciences Division, Stritch School of Medicine, Maywood, IL, 60153, USA

    Alan J Wolfe

  18. Department of Biomedical Engineering, Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, ND20, Cleveland, OH, 44195, USA

    Margot S Damaser

  19. Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA

    Margot S Damaser

Authors
  1. Benjamin Abelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lauren Que
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rebecca A Nebel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dylan Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrick Popiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cindy L Amundsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Toby Chai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Clare Close
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael DiSanto
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Matthew O Fraser
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Stephanie J Kielb
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. George Kuchel
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Elizabeth R Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Mary H Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Candace Parker-Autry
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Alan J Wolfe
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Margot S Damaser
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BA, DS, LQ, RAN, and MD were major contributors in conceiving and writing the manuscript. All other authors contributed to the writing of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Margot S Damaser.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

Dr. Wolfe has received research funding from Astellas Scientific Medical Affairs and Kimberly Clark Corporation. All other authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abelson, B., Sun, D., Que, L. et al. Sex differences in lower urinary tract biology and physiology. Biol Sex Differ 9, 45 (2018). https://doi.org/10.1186/s13293-018-0204-8

Download citation

Keywords

  • Sex differences
  • Lower urinary tract
  • Cell biology
  • Urology

Biology of Sex Differences

ISSN: 2042-6410

Contact us